Chemcrux Enterprises Limited (CHEMCRUX) fundamentals
Chemcrux Enterprises Limited is a listed company, part of the Chemicals sector, listed on the NSE as CHEMCRUX (ISIN INE298W01016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Chemcrux Enterprises Limited does
Chemcrux Enterprises Limited is an India-based company. The Company is engaged in the business of manufacturing or processing of bulk drug intermediates like para chloro benzoic, ortho benzoic acid, and lasamide, and others. The Company's products include 2-Chloro Benzoic Acid, 3-Chloro Benzoic Acid, 4-Chloro Benzoic Acid, 2,4-Dichloro Benzoic Acid, 4-Chloro 3-Nitro Benzoic Acid; 2-Chloro 5-Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lasamide, and Meta Chloro Per Benzoic Acid, Para Chloro Benzoyl Chloride, Ortho Chloro Benzoyl Chloride, 2,4-Dichloro Benzoyl Chloride, 2,3-Dichloro Benzoyl Chloride. It is engaged in the development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation, BPEA Sulfonamide and Chlorosulfonation. The Company caters to both the domestic and international markets. The Company’s manufacturing facility is located in Bharuch, Gujarat, India.
Valuation and market data
| Last close | ₹82.40 |
|---|---|
| Market capitalisation | ₹122 crore |
| Enterprise value | ₹146 crore |
| P/E (TTM) | 32.70 |
| Price to book | 1.59 |
| Price to sales (TTM) | 0.85 |
| Book value per share | ₹51.92 |
| Dividend yield | 121.36% |
| Sector | Chemicals |
| Industry | — |
| Listed since | Mon Aug 17 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹85 crore | ₹7 crore | ₹5 crore | 3.68 |
| Mar 2025 | ₹72 crore | ₹6 crore | ₹4 crore | 2.83 |
| Mar 2024 | ₹80 crore | ₹11 crore | ₹8 crore | 5.70 |
| Mar 2023 | ₹96 crore | ₹20 crore | ₹14 crore | 9.70 |
| Mar 2022 | ₹96 crore | ₹20 crore | ₹15 crore | 10.03 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 72.9% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 27.1% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.